NSC-632839

Suppliers

Names

[ CAS No. ]:
157654-67-6

[ Name ]:
NSC-632839

[Synonym ]:
(3E,5E)-3,5-Bis(4-methylbenzylidene)-4-piperidinone hydrochloride (1:1)
4-Piperidinone, 3,5-bis[(4-methylphenyl)methylene]-, (3E,5E)-, hydrochloride (1:1)
NSC632839

Chemical & Physical Properties

[ Boiling Point ]:
522.7ºC at 760 mmHg

[ Molecular Formula ]:
C21H22ClNO

[ Molecular Weight ]:
339.858

[ Flash Point ]:
184ºC

[ Exact Mass ]:
339.138977

[ PSA ]:
29.10000

[ LogP ]:
5.07350

[ Vapour Pressure ]:
5.05E-11mmHg at 25°C

[ Storage condition ]:
-20℃

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H319

[ Precautionary Statements ]:
P305 + P351 + P338

[ RIDADR ]:
UN 3077 9 / PGIII

Articles

Palmitoleate Reverses High Fat-induced Proinflammatory Macrophage Polarization via AMP-activated Protein Kinase (AMPK).

J. Biol. Chem. 290 , 16979-88, (2015)

A rise in tissue-embedded macrophages displaying "M1-like" proinflammatory polarization is a hallmark of metabolic inflammation during a high fat diet or obesity. Here we show that bone marrow-derived...

Synthesis, evaluation and molecular docking studies of amino acid derived N-glycoconjugates as antibacterial agents.

Bioorg. Chem. 63 , 110-5, (2015)

Six amino acid derived N-glycoconjugates of d-glucose were synthesized, characterized and tested for antibacterial activity against G(+)ve (Bacillus cereus) as well as G(-)ve (Escherichia coli and Kle...

In vitro-in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623.

Eur. J. Pharm. Biopharm. 88(3) , 973-85, (2014)

The present study investigated the use of lipid based drug delivery systems to enhance the oral bioavailability of the CETP inhibitors CP-532,623 and torcetrapib. A series of self-emulsifying lipid ba...


More Articles

Related Compounds

  • NSC 319726
  • NSC 668036
  • NSC 80467
  • NSC 83128-d3
  • nsc 663887
  • NSC-87877 disodium
  • 2-{[4-amino-5-(thiophene-2-sulfonyl)pyrimidin-2-yl]sulfanyl}-N-(2H-1,3-benzodioxol-5-yl)acetamide
  • 2-{[4-amino-5-(thiophene-2-sulfonyl)pyrimidin-2-yl]sulfanyl}-N-[3-(methylsulfanyl)phenyl]acetamide
  • 2-(5-amino-2-oxo-1,2-dihydropyridin-1-yl)-N-benzylacetamide
  • 2-(4-Amino-1H-pyrazol-1-YL)-N-benzylacetamide
  • 2-(4-amino-3,5-dimethyl-1H-pyrazol-1-yl)-N-benzylacetamide
  • 2-[3-(Aminothioxomethyl)phenoxy]-N-(phenylmethyl)acetamide
  • 2-{[4-amino-5-(thiophene-2-sulfonyl)pyrimidin-2-yl]sulfanyl}-N-benzylacetamide
  • 1-(Benzylcarbamoyl-methyl)-6-oxo-1,6-dihydro-pyridine-3-carboxylic acid
  • 3-cyclopropyl-2-({[3-(pyridin-2-yl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)-3H,4H-thieno[3,2-d]pyrimidin-4-one
  • 3-cyclopropyl-2-({[3-(2,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)-3H,4H-thieno[3,2-d]pyrimidin-4-one